shown in TDT patients worldwide(8), which in turn puts another emphasis on the importance of HCV treatment in this group of patients.History of HCV Treatment in ThalassemiaInterferon-alpha (IFN-a ) monotherapy is currently approved as the first line treatment for HCV infection in TDT patients....
atom has a toy car his parents have a stove 汤姆有一辆玩具汽车他的父母有火炉[translate] a这就是我的晚上 This is my evening[translate] aserve as an alternative treatment modality for HCV infection 起一种供选择的治疗形式作用对于HCV传染[translate]...
Treatment of hepatitis C virus (HCV) infection significantly improved between the years 1995 and 2002. The introduction of interferon alfa plus ribavirin combination therapy and the development of pegylated interferons have led to an impressive increase in the achievement of virologic treatment responses ...
Undetectable HCV-RNA at week 4 of treatment was defined as rapid virological response (RVR). When RVR was persistent in the following weeks it was defined as extended RVR (eRVR). Relapse occurs when HCV RNA decreases and remains below the limit of detection during treatment but becomes detecta...
Treatment of Chronic HCV Infection in Patients With ThalassemiaWatch a video presentation of this article Watch the interview with the author Answer questions and earn CMEdoi:10.1002/cld.853Halim Bou DaherAla I. ShararaJohn Wiley & Sons, LtdClinical Liver Disease...
in 25% of patients. HBV/HCV coinfection is associated with more severe liver disease, with an increased risk for hepatic decompensation and more rapid development of hepatocellular carcinoma. HBV/HCV coinfection is associated with a higher mortality rate compared with HBV or HCV mono-infection. ...
Treatment for HCV is available and cost-effective [6]; it cures 45% of patients with HCV genotype 1 infection and 75% of those with HCV genotype 2 or genotype 3 infection [7–9]. The current recommendations for the treatment of hepatitis C in mono-infected and HIV-HCV co-infected patien...
Individuals withopioid use disorderare a particularly challenging underserved population to treat in conventional health care settings, and they are at highest risk for hepatitis C virus (HCV) infection through needle sharing. University at Buffalo researchers explored the effectiveness of integrating teleme...
Background Telaprevir (TVR) has been approved for response-guided-therapy (RGT) of chronic hepatitis C (HCV) genotype-1-infection in treatment-na??ve and ???experienced patients. In RGT-regimens patients that did not achieve extended rapid-virological-response (eRVR) within the first 4???12...
Hepatitis C (HCV) infection is associated with high rates of mortality and morbidity. Interferon alpha based treatment for HCV offers a good rate of viral clearance, however the associated neuropsychiatric side effects increase the risk of treatment interruption and disease progression. The HIV/HCV co...